Cell cycle models and mother-daughter correlation.

Lineage correlations of single cell division time as a probe of cell-cycle dynamics. Nature (2015) 1.14

A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat Med (2004) 5.90

Understanding the dynamics of Ebola epidemics. Epidemiol Infect (2006) 5.81

A computer network for the surveillance of communicable diseases: the French experiment. Am J Public Health (1986) 5.38

Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med (2000) 3.95

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet (2003) 3.23

Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet (1996) 3.15

Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS (1998) 2.90

Surveillance of influenza-like illness in France. The example of the 1995/1996 epidemic. J Epidemiol Community Health (1998) 2.86

What is known about the prevention of congenital toxoplasmosis? Lancet (1990) 2.78

Epidemiologic mapping using the "kriging" method: application to an influenza-like illness epidemic in France. Am J Epidemiol (1992) 2.76

Modelling the 1985 influenza epidemic in France. Stat Med (1988) 2.70

Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology (1990) 2.58

Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis (1999) 2.49

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet (1996) 2.41

Modeling the spread of resistant nosocomial pathogens in an intensive-care unit. Infect Control Hosp Epidemiol (1997) 2.16

Patterns of disclosure and perceptions of the human immunodeficiency virus in infected elementary school-age children. Arch Pediatr Adolesc Med (1997) 2.14

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor. AIDS (2000) 2.14

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut (1994) 2.03

Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia. Br J Haematol (1990) 2.02

Virtual surveillance of communicable diseases: a 20-year experience in France. Stat Methods Med Res (2006) 1.98

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood (2001) 1.98

Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy. Blood (2001) 1.95

Sentiweb: French communicable disease surveillance on the World Wide Web. BMJ (1996) 1.94

A routine tool for detection and assessment of epidemics of influenza-like syndromes in France. Am J Public Health (1991) 1.90

A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol (1997) 1.85

Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. Am J Epidemiol (1995) 1.84

Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups. AIDS (1999) 1.80

Computer networking as a tool for public health surveillance: the French experiment. MMWR Morb Mortal Wkly Rep (1992) 1.75

Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) Gastroenterology (1993) 1.71

Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer (1984) 1.71

Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science (2000) 1.70

Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clin Infect Dis (2001) 1.68

Sentinelle traces of an epidemic of acute gastroenteritis in France. Lancet (1995) 1.67

The French Communicable Diseases Computer Network. A seven-year experiment. Ann N Y Acad Sci (1992) 1.66

A mathematical model for the European spread of influenza. Eur J Epidemiol (1994) 1.64

Modeling the hepatitis C virus epidemic in France. Hepatology (1999) 1.61

Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride). Gut (1985) 1.60

Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab (2001) 1.58

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial. Gut (2005) 1.58

Trends in primary liver cancer. Lancet (1998) 1.56

Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood (1998) 1.56

Anal lesions: any significant prognosis in Crohn's disease? Eur J Gastroenterol Hepatol (1997) 1.49

A mathematical model for evaluating the impact of vaccination schedules: application to Neisseria meningitidis. Epidemiol Infect (2003) 1.46

Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum (2001) 1.44

Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost-effective. Vox Sang (2001) 1.40

Lack of association between human leukocyte antigens and the anti-Hu syndrome in patients with small-cell lung cancer. Neurology (1998) 1.39

Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood (1995) 1.39

Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution? Gut (1997) 1.38

Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood (1999) 1.36

FluNet as a tool for global monitoring of influenza on the Web. JAMA (1998) 1.31

Planning a reproducibility study: how many subjects and how many replicates per subject for an expected width of the 95 per cent confidence interval of the intraclass correlation coefficient. Stat Med (2001) 1.30

Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy. HIV Med (2008) 1.29

A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Am J Gastroenterol (1999) 1.27

Attitude of French general practitioners to the public health surveillance of communicable diseases. Int J Epidemiol (1995) 1.27

Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med (1998) 1.26

Influenza mortality among the elderly in France, 1980-90: how many deaths may have been avoided through vaccination? J Epidemiol Community Health (1995) 1.24

Epidemiology of aplastic anemia in France: a case-control study. I. Medical history and medication use. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood (1993) 1.22

Record-linkage between two anonymous databases for a capture-recapture estimation of underreporting of AIDS cases: France 1990-1993. The Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine. Int J Epidemiol (2000) 1.21

Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol (2001) 1.19

Recent reduction in male urethritis in France. Am J Public Health (1989) 1.16

The risk of diabetic control: a comparison of hospital versus general practice supervision. Diabetologia (1982) 1.16

Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy. AIDS (2000) 1.15

Factors related to sexual intercourse frequency in a group of French pre-retirement managers. Age Ageing (1981) 1.14

Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19). HIV Med (2009) 1.10

A model to predict the outcome of the bilharzial bladder cancer patient after radical cystectomy. Br J Cancer (1987) 1.09

Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol (2011) 1.09

The cost of diabetes in France. Health Policy (1988) 1.08

Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication. AIDS (2005) 1.07

Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe. J Viral Hepat (1999) 1.06

Monitoring the compliance of sentinel general practitioners in public health surveillance: which GPs persevere? Int J Epidemiol (1997) 1.05

Comparison of weight- and height-based indices for assessing the risk of death in severely malnourished children. Am J Epidemiol (1996) 1.03

Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus. J Infect Dis (2002) 1.03

Epidemiology of toxoplasmosis among pregnant women in the Paris area. Int J Epidemiol (1988) 1.03

A simulation model of the natural history of human breast cancer. Br J Cancer (1985) 1.02

Number of deaths among HIV-infected adults in France in 2000, three-source capture-recapture estimation. Epidemiol Infect (2006) 1.02

Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method. AIDS (1997) 1.02

Imprecision of new criteria for the oral glucose tolerance test. Diabetologia (1983) 1.02

HIV and travel, no rationale for restrictions. Lancet (1990) 1.02

A model to standardise mortality of severely malnourished children using nutritional status on admission to therapeutic feeding centres. Eur J Clin Nutr (1997) 1.01

Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology (1999) 1.01

A prospective evaluation of clinical criteria and polymerase chain reaction assay of cerebrospinal fluid for the diagnosis of cytomegalovirus-related neurological diseases during AIDS. AIDS (1995) 1.00

Primary prevention with cotrimoxazole for HIV-1-infected adults: results of the pilot study in Dakar, Senegal. J Acquir Immune Defic Syndr (2001) 1.00

Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1996) 1.00

Prevalence of obesity: a comparative survey in France, the United Kingdom and the United States. Int J Obes Relat Metab Disord (1992) 0.99

Visit-driven endpoints in randomized HIV/AIDS clinical trials: impact of missing data on treatment difference measured on summary statistics. Stat Med (1999) 0.99

Sucrose taken during mixed meal has no additional hyperglycaemic action over isocaloric amounts of starch in well-controlled diabetics. Lancet (1984) 0.98

Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV. AIDS (1999) 0.97

Mortality of workers in a French asbestos cement factory 1940-82. Br J Ind Med (1985) 0.97

Penicillin-resistant pneumococcal meningitis: high antibiotic exposure impedes new vaccine protection. Epidemiol Infect (2005) 0.97

Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet (2000) 0.97

Initiation of insulin treatment after 70 years of age: patient status 2 years later. Diabet Med (1991) 0.96

Effects of cholecystokinin and metoclopramide on jejunal movements of water and electrolytes and on transit time of luminal fluid in man. Eur J Clin Invest (1972) 0.96

Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients. J Antimicrob Chemother (2010) 0.96

High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy. AIDS (1998) 0.96

How does loss to follow-up influence cohort findings on HIV infection? A joint analysis of the French hospital database on HIV, Mortalité 2000 survey and death certificates. HIV Med (2008) 0.95

'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study. AIDS (2001) 0.95

Six years of public health surveillance of measles in France. Int J Epidemiol (1992) 0.95

Modelling responses to a smallpox epidemic taking into account uncertainty. Epidemiol Infect (2004) 0.95

HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression. AIDS Res Hum Retroviruses (2001) 0.95